The research demonstrates improved efficacy in cancer immunotherapy using three-dimensional hydrogel networks, suggesting minimized adverse events.
Cancer immunotherapies, including chimeric antigen receptor (CAR) T-cell and immune checkpoint blockade (ICB) therapy, have revolutionized oncological treatment. However, suboptimal patient response rates and immune-related adverse events continue to pose...
No takes yet. Share an insight, caveat, or question.
Mamidi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: